St. Jude Medical Inc.’s Unify Quadra became the first cardiac resynchronization therapy defibrillator system with a quadripolar pacing lead approved by FDA Nov. 29, at least six months behind the firm’s initial target date.
The product represents an important technological advancement in the cardiac rhythm management space, and it is likely to give St....